Juan Camilo Sarmiento-Monroy

Mr. Juan Camilo Sarmiento-Monroy

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2016 in Expert Review of Clinical Immunology
Verified
Journal Article
Closed access
AJAnil K. Jasti
Anil K. Jasti
CSCarlo Selmi
Carlo Selmi
JSJuan Camilo Sarmiento-Monroy
Juan Camilo Sarmiento-Monroy
DVDaniel A. Vega
Daniel A. Vega
Juan-Manuel AnayaJuan-Manuel Anaya
Juan-Manuel Anaya
MGM. Eric Gershwin
M. Eric Gershwin
Guillain-Barré syndrome is a rare disease representing the most frequent cause of acute flaccid symmetrical weakness of the limbs and areflexia usually reaching its peak within a month. The etiology and pathogenesis remain largely enigmatic and the syndrome results in death or severe disability in 9-17% of cases despite immunotherapy. Areas covered: In terms of etiology, Guillain-Barré syndrome is linked to Campylobacter infection but less than 0.1% of infections result in the syndrome. In terms of pathogenesis, activated macrophages and T cells and serum antibodies against gangliosides are observed but their significance is unclear. Expert commentary: Guillain-Barré syndrome is a heterogeneous condition with numerous subtypes and recent data point towards the role of ganglioside epitopes by immunohistochemical methods. Ultimately, the syndrome results from a permissive genetic background on which environmental factors, including infections, vaccination and the influence of aging, lead to disease.

1 August 2016 in Rheumatic Disease Clinics of North America
Verified
Journal Article
Closed access
Juan-Manuel AnayaJuan-Manuel Anaya
Juan-Manuel Anaya
ARAdriana Rojas-Villarraga
Adriana Rojas-Villarraga
RMRuben D. Mantilla
Ruben D. Mantilla
MAMauricio Arcos-Burgos
Mauricio Arcos-Burgos
JSJuan Camilo Sarmiento-Monroy
Juan Camilo Sarmiento-Monroy

1 August 2016 in Autoimmunity Reviews
Verified
Journal Article
Closed access
Juan-Manuel AnayaJuan-Manuel Anaya
Juan-Manuel Anaya
CDCarolina Duarte-Rey
Carolina Duarte-Rey
JSJuan Camilo Sarmiento-Monroy
Juan Camilo Sarmiento-Monroy
DBDavid Bardey
David Bardey
JCJohn Castiblanco
John Castiblanco
ARAdriana Rojas-Villarraga
Adriana Rojas-Villarraga

13 April 2013 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
JAJenny Amaya-Amaya
Jenny Amaya-Amaya
JSJuan Camilo Sarmiento-Monroy
Juan Camilo Sarmiento-Monroy
RMRuben-Dario Mantilla
Ruben-Dario Mantilla
RPRicardo Pineda-Tamayo
Ricardo Pineda-Tamayo
ARAdriana Rojas-Villarraga
Adriana Rojas-Villarraga
Juan-Manuel AnayaJuan-Manuel Anaya
Juan-Manuel Anaya

31 October 2012 in Arthritis
Verified
Journal Article
Open access
PDF file
JSJuan Camilo Sarmiento-Monroy
Juan Camilo Sarmiento-Monroy
JAJenny Amaya-Amaya
Jenny Amaya-Amaya
JEJuan Sebastián Espinosa-Serna
Juan Sebastián Espinosa-Serna
CHCatalina Herrera-Díaz
Catalina Herrera-Díaz
Juan-Manuel AnayaJuan-Manuel Anaya
Juan-Manuel Anaya
ARAdriana Rojas-Villarraga
Adriana Rojas-Villarraga
Background. Cardiovascular disease (CVD) is the major predictor of poor prognosis in rheumatoid arthritis (RA) patients. There is an increasing interest to identify “nontraditional” risk factors for this condition. Latin Americans (LA) are considered as a minority subpopulation and ethnically different due to admixture characteristics. To date, there are no systematic reviews of the literature published in LA and the Caribbean about CVD in RA patients.Methods. The systematic literature review was done by two blinded reviewers who independently assessed studies for eligibility. The search was completed through PubMed, LILACS, SciELO, and Virtual Health Library scientific databases.Results. The search retrieved 10,083 potential studies. A total of 16 articles concerning cardiovascular risk factors and measurement of any cardiovascular outcome in LA were included. The prevalence of CVD in LA patients with RA was 35.3%. Non-traditional risk factors associated to CVD in this population were HLA-DRB1 shared epitope alleles, rheumatoid factor, markers of chronic inflammation, long duration of RA, steroids, familial autoimmunity, and thrombogenic factors.Conclusions. There is limited data about CVD and RA in LA. We propose to evaluate cardiovascular risk factors comprehensively in the Latin RA patient and to generate specific public health policies in order to diminish morbi-mortality rates.

13 August 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
AFAndrés Ponce Fernández
Andrés Ponce Fernández
BFBeatriz Frade-Sosa
Beatriz Frade-Sosa
JSJuan Camilo Sarmiento-Monroy
Juan Camilo Sarmiento-Monroy
NSNuria Sapena
Nuria Sapena
JRJulio Ramírez
Julio Ramírez
JGJosé A Gómez-Puerta
José A Gómez-Puerta
Immune checkpoint inhibitor (ICI)-induced arthritis is an increasingly recognized adverse event in patients with oncologic disease during immunotherapy. Four patterns are well described, including rheumatoid arthritis (RA)-like, polymyalgia rheumatica (PMR)-like, psoriatic arthritis (PsA)-like, and oligo-monoarthritis, among others. Despite better clinical recognition of these syndromes, information about the main imaging findings is limited. Methods: We conducted a retrospective observational study including all adult patients referred to the Rheumatology Department of a single-center due to ICI-induced arthritis who underwent imaging studies [ultrasound (US), magnetic resonance imaging (MRI), and 18F-FDG PET/CT)] between January 2017 and January 2022. Results: Nineteen patients with ICI-induced arthritis with at least one diagnostic imaging assessment were identified (15 US, 4 MRI, 2 18F-FDG PET/CT). Most patients were male (84.2%), with a median age at inclusion of 73 years. The main underlying diagnoses for ICI treatment were melanoma in five cases. The distribution of ICI-induced arthritis was as follows: PMR-like (5, 26.2%), RA-like (4, 21.1%), PsA-like (4, 21.1%), and others (6, 31.6%). All RA-like patients had US findings indistinguishable from conventional RA patients. In addition, 3/5 (60%) of PMR-like patients had significant involvement of the hands and wrists. Abnormal findings on MRI or PET-CT were reported by clinical symptoms. No erosions or myofascitis were seen. Conclusions: ICI-induced arthritis patients present inflammatory patterns on imaging studies similar to conventional inflammatory arthropathies, and therefore these syndromes should be followed carefully and treated according to these findings.